Bacteria: Gram-negative

Neisseria gonorrhoeae

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

A Gram-negative diplococcus transmitted sexually and the cause of gonorrhea.

Infections

Urethritis, cervicitis, pharyngeal and rectal infection, pelvic inflammatory disease, epididymitis, disseminated gonococcal infection, neonatal conjunctivitis.

Signs and symptoms

Urethral or vaginal discharge, dysuria, pelvic pain; many infections, especially in women and at the pharynx, cause no symptoms.

Antibiotic and antimicrobial resistance

Has developed resistance to many antibiotic classes; ceftriaxone remains the recommended treatment.

Treatment considerations

Ceftriaxone per CDC guidelines, with treatment for chlamydia if not excluded; test of cure for pharyngeal infection.

Infection control and public health

Nationally notifiable; partner notification and treatment.

Fluorescent green Neisseria gonorrhoeae diplococci, fluorescent antibody stain
Neisseria gonorrhoeae, fluorescent antibody stain. CDC Public Health Image Library; public domain. Image source
Gram-negative diplococci, schematic
Gram-negative diplococci. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Gonococcal infections (STI Treatment Guidelines).
  2. CDC. Sexually Transmitted Infections Treatment Guidelines, 2021.
  3. CDC. Antimicrobial Resistance: Threats and data.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.